![]() 2,6-Dihydroxybenzoic acid structure
|
Common Name | 2,6-Dihydroxybenzoic acid | ||
---|---|---|---|---|
CAS Number | 303-07-1 | Molecular Weight | 154.120 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 343.7±32.0 °C at 760 mmHg | |
Molecular Formula | C7H6O4 | Melting Point | 165 °C (dec.)(lit.) | |
MSDS | Chinese USA | Flash Point | 175.8±21.6 °C |
Use of 2,6-Dihydroxybenzoic acid2,6-Dihydroxybenzoic acid is a secondary metabolite of salicylic acid which has been hydrolyzed by liver enzymes during phase I metabolism. |
Name | 2,6-dihydroxybenzoic acid |
---|---|
Synonym | More Synonyms |
Description | 2,6-Dihydroxybenzoic acid is a secondary metabolite of salicylic acid which has been hydrolyzed by liver enzymes during phase I metabolism. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 343.7±32.0 °C at 760 mmHg |
Melting Point | 165 °C (dec.)(lit.) |
Molecular Formula | C7H6O4 |
Molecular Weight | 154.120 |
Flash Point | 175.8±21.6 °C |
Exact Mass | 154.026611 |
PSA | 77.76000 |
LogP | 2.24 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.671 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
---|---|
Hazard Codes | Xi:Irritant |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | DG8578000 |
HS Code | 29182990 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2918290000 |
---|---|
Summary | HS: 2918290000 other carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) VAT:17.0% MFN tariff:6.5% General tariff:30.0% |
Antimicrobial activity of natural products from the flora of Northern Ontario, Canada.
Pharm. Biol. 53(6) , 800-6, (2015) The number of multidrug resistant (MDR) microorganisms is increasing and the antimicrobial resistance expressed by these pathogens is generating a rising global health crisis. In fact, there are only ... |
|
Molecularly imprinted polymers with synthetic dummy template for simultaneously selective removal and enrichment of ginkgolic acids from Ginkgo biloba L. leaves extracts.
J. Chromatogr. A. 1368 , 44-51, (2014) Dummy molecularly imprinted polymers (DMIPs) for simultaneously selective removal and enrichment of ginkgolic acids (GAs) during the processing of Ginkgo biloba leaves have been prepared. Two dummy te... |
|
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
J. Med. Chem. 54 , 591-602, (2011) Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors. When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compounds produced... |
EINECS 206-134-8 |
Gamma-Resorcylic Acid |
2-Carboxyresorcinol |
γ-Resorcylic acid |
Benzoic acid,2,6-dihydroxy |
2,6-dihydroxy-benzoic acid |
2,5-DIFLUOROBENZYLSULFONAMIDE |
2,6-Dihydroxybenzoic acid |
g-Resorcylic Acid |
2,6-Resorcylic acid |
6-Hydroxysalicylic acid |
MFCD00002462 |
Benzoic acid, 2,6-dihydroxy- |